Skip to content

CHEMICAL PEELS FOR MACULAR AMYLOIDOSIS: A STUDY OF 15% TRICHLOROACETIC ACID PEEL VERSUS 35% GLYCOLIC ACID PEEL.

A RANDOMISED CONTROL STUDY TO EVALUATE THE EFFICACY AND SAFETY OF 15% TRICHLOROACETIC ACID PEEL VERSUS 35% GLYCOLIC ACID PEEL IN PATIENTS WITH CUTANEOUS MACULAR AMYLOIDOSIS. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/082200
Enrollment
48
Registered
2025-03-12
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L818- Other specified disorders of pigmentation

Interventions

Intervention1: 15% TRICHLOROACETIC ACID CHEMICAL PEEL: 15% TRICHLOROACETIC ACID IS SUPERFICIAL MEDIUM DEPTH PEEL, CAUSES PROTEIN COAGULATION AND NECROSIS, LEADING TO EPIDERMAL PEELING AND REGENERATION

Sponsors

DR RACHANA DOLLI
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients willing to give informed consent 2. Adults aged 18-60 years. 3. Diagnosed with primary cutaneous macular amyloidosis. 4. No prior treatment with TCA or GA peels. 5. Willing to comply with the follow-up schedule.

Exclusion criteria

Exclusion criteria: 1.Pregnant or lactating women. 2.History of hypersensitivity to TCA or GA. 3.Presence of other active skin diseases or infections at the site. 4.Use of systemic retinoids within the past 6 months. 5.History of keloid or hypertrophic scar formation

Design outcomes

Primary

MeasureTime frame
IMPROVEMENT IN THE PIGMENTATION OF SKIN. IMPROVEMENT IN THE SYMPTOMS LIKE PRURITIS.Timepoint: AT 4WEEKS, 8WEEKS, 12WEEKS AND 16WEEKS.

Secondary

MeasureTime frame
TO RECORD THE ADVERSE REACTIONS TO CHEMICAL PEELS. EVALUATE PATIENT SATISFACTION WITH TREATMENT.Timepoint: ADVERSE REACTIONS TO CHEMICAL WILL BE RECORDED IMMEDIATELY AFTER PROCEDURE AND 2 DAYS POST PROCEDURE. PATIENT SATISFACTION WITH THE TREATMENT WILL BE RECORED AT 16 WEEKS.

Countries

India

Contacts

Public ContactDR SHILPA K

BANGALORE MEDICAL COLLEGE AND RESEARCH INSTITUTE, BENGALURU, KARNATAKA.

shilpakvinod1980@gmai.com9886553646

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026